Monthly Archives: April 2025

MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) Drug alert number: EL(25)A/18 Date issued: 24 April 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Brilique 90mg tablets (G Pharma Ltd) as G Pharma Ltd have informed the MHRA that there is [...]

The post MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on prescription switching. For the end-of-month submission, pharmacy teams are required to sort paper prescriptions into paid and exempt groups. Prescription switching occurs when an FP10 paper prescription is submitted in the wrong charge [...]

The post Funding & Reimbursement Shorts: Prescription switching appeared first on Community Pharmacy England.

The Government is yet to conclude consideration of any increases to prescription charges and NHS prescription pre-payment certificates (PPCs) for 2025/26. Therefore, the current charges will roll over into May 2025. Community Pharmacy England will update community pharmacy teams as soon as any changes are announced by Ministers, including details of when they will be [...]

The post £9.90 NHS prescription and PPC charges unchanged for May 2025 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (22/04/2025) confirmed the following initial list of price concessions for April 2025.  Drug Pack size Price concession Alendronic acid 70mg tablets 4 £1.15 Chloramphenicol 1% eye ointment 4 £3.08 Clarithromycin 125mg/5ml oral suspension 70 £6.30 Duloxetine 30mg gastro-resistant capsules 28 £1.99 Duloxetine 60mg gastro-resistant capsules [...]

The post April 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

NHS England (NHSE) has confirmed that all remaining supplies of Government procured COVID-19 antiviral medicine Paxlovid® (Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets) will expire on 31 May 2025. This follows the recent deletion of Lagevrio® (Molnupiravir 200mg capsules) from Part VIIIC of the April 2025 Drug Tariff after Government stock of Lagevrio® expired on [...]

The post Expiry of Government stockpile of Paxlovid® (Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets) appeared first on Community Pharmacy England.